-
8801
-
8802
Recurrent maternal CMV infection associated with symptomatic congenital infection: results from a questionnaire study in Portugal
Published 2019-09-01“…The odds for non-primary maternal infection if the offspring was symptomatic at birth were 6.2 (95% CI 1.2 to 32.27).Conclusion The reported number of confirmed cases of congenital CMV infection was much lower than expected. …”
Get full text
Article -
8803
-
8804
The Dataset Finder: A Tool Utilizing Data Management Plans as a Key to Data Discoverability
Published 2024-12-01Get full text
Article -
8805
Gross and Morphometric Anatomy of the Male Reproductive System of Bats (Eidolon helvum)
Published 2014-01-01“…Morphologically, the mean body weight and forearm length in both adults and juveniles were 235.31±6.30 g, 12.14±0.19 cm and 69.54±7.68 g, 7.77±0.29 cm, respectively. …”
Get full text
Article -
8806
-
8807
-
8808
archNEMESIS: An Open-Source Python Package for Analysis of Planetary Atmospheric Spectra
Published 2025-07-01Get full text
Article -
8809
-
8810
Case Report: Pediatric respiratory viral infection failure: a case series of eight fatalities in children under 5 years old in Iran
Published 2025-05-01“…According to the World Health Organization (WHO), ARTI leads to the hospitalization of over 12 million children annually, with approximately one million fatalities, one-third of which occur in low-income countries. …”
Get full text
Article -
8811
-
8812
-
8813
Risk Factors for Stiffness After Fixation of Tibial Tubercle Fractures: A Multicenter Study From the TITUS Group
Published 2025-09-01“…Fractures with <3 months of documented postoperative range of motion and those fixed with nonscrew implants were excluded. …”
Get full text
Article -
8814
Seroprevalence and risk factors for sheep pox and goat pox among small ruminant herds from Nakapiripirit and Sembabule districts, Uganda
Published 2025-07-01“…Seropositivity was greater in Nakapiripirit [n = 93, 12%] than in Sembabule districts [n = 44, 6%]. Although low in proportion, overall, from both districts, seropositivity among sheep [N = 296, n = 32,12%] was higher than goats [N = 1,219, n = 105,10%]. …”
Get full text
Article -
8815
Outcomes of chronic pectoralis major rupture repair with implant-free Achilles allograft
Published 2025-08-01“…The mean delay in diagnosis and treatment was 5.5 months (2-12) and 12 ± 4.9 months, respectively. The overall cohort improved significantly regarding pain (visual analog scale: −6 [95% CI: −2.3 to −9.7], P = .014) and patient-reported outcome measures (American Shoulder and Elbow Surgeons: 23 [95% CI: 14.6-31.4], P = .003; Constant score: 38.8 [95% CI: 9.3-68.2], and P = .025; subjective shoulder value: 45 [95% CI: 0.5-89.5], P = .049). …”
Get full text
Article -
8816
Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignancies
Published 2025-08-01“…Abstract Background The US Food and Drug Administration (FDA) released a draft guidance document detailing core patient-reported outcomes in cancer clinical trials, including physical function (PF). …”
Get full text
Article -
8817
Strategies for implementing long‐acting cabotegravir for PrEP in US clinics serving Black women: interim healthcare provider findings from the EBONI study
Published 2025-07-01“…Useful implementation strategies unique to clinic types included using electronic medical records to document whether patients were offered CAB LA (PC), designating specific days for administering injections (WH) and creating time for discussion with patients (ID). …”
Get full text
Article -
8818
Screening log: Challenges in community patient recruitment for gynecologic oncology clinical trials
Published 2024-12-01“…Re-screening patients when new trials open may identify 12-15 additional patients per recurrent disease trial. …”
Get full text
Article -
8819
Suppression of the T-dependent antibody response following oral exposure to selected polycyclic aromatic compounds in B6C3F1/N mice
Published 2025-03-01“…In addition, phenanthrene and pyrene, non-carcinogenic PACs, were tested at dose ranges between 12.5 and 800 mg/kg bodyweight/day and 3.1 and 200 mg/kg bodyweight/day, respectively. …”
Get full text
Article -
8820
Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety
Published 2021-11-01“…Ventricular arrhythmias (exclusively Torsade de pointes tachycardia in excessive QT interval prolongation) were registered in 1.7% (12 of 727) patients: in 2% (9 of 451) of patients in primary center and in 1% (3 of 276) of patients of other hospitals; 95% CI: [-0.06; 0.08]. …”
Get full text
Article